Dangos 1 - 5 canlyniadau o 5 ar gyfer chwilio 'Seyed Reza Mousavi (13223324)', amser ymholiad: 0.01e Mireinio'r Canlyniadau
  1. 1
    The non-inferiority margin in Phase III clinical trial of SnaFab compared to Razi antivenom in snakebites.

    The non-inferiority margin in Phase III clinical trial of SnaFab compared to Razi antivenom in snakebites. gan Seyed Reza Mousavi (13223324)

    Cyhoeddwyd 2025
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  2. 2
    Snakebite severity classification in clinical trial of SnaFab vs. Razi antivenom in snakebite victims [14,57,58].

    Snakebite severity classification in clinical trial of SnaFab vs. Razi antivenom in snakebite victims [14,57,58]. gan Seyed Reza Mousavi (13223324)

    Cyhoeddwyd 2025
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  3. 3
    Adverse events during follow-up period in Phase III non-inferiority clinical trial of SnaFab compared to Razi antivenom in snakebites.

    Adverse events during follow-up period in Phase III non-inferiority clinical trial of SnaFab compared to Razi antivenom in snakebites. gan Seyed Reza Mousavi (13223324)

    Cyhoeddwyd 2025
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  4. 4
    Consort Chart of Phase III clinical trial of SnaFab compare to Razi antivenom in snakebites.

    Consort Chart of Phase III clinical trial of SnaFab compare to Razi antivenom in snakebites. gan Seyed Reza Mousavi (13223324)

    Cyhoeddwyd 2025
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  5. 5
    Demographic information and clinical presentation of victims in Phase III non-inferiority clinical trial of SnaFab compare to Razi antivenom in snakebites.

    Demographic information and clinical presentation of victims in Phase III non-inferiority clinical trial of SnaFab compare to Razi antivenom in snakebites. gan Seyed Reza Mousavi (13223324)

    Cyhoeddwyd 2025
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:

Offerynnau Chwilio: